Time to reconsider risk stratification in dilated cardiomyopathy

Hellenic J Cardiol. 2021 Sep-Oct;62(5):392-393. doi: 10.1016/j.hjc.2021.03.008. Epub 2021 Apr 8.

Authors

Affiliations

¹ First Department of Cardiology, National and Kapodistrian University of Athens, Hippokrateion Hospital, Athens, Greece.
² First Department of Cardiology, National and Kapodistrian University of Athens, Hippokrateion Hospital, Athens, Greece. Electronic address: kgatzoul@med.uoa.gr.
³ Athens Heart Center, Athens Medical Center, Athens, Greece.
⁴ State Department of Cardiology, Hippokrateion Hospital, Athens, Greece.

PMID: 33839282
DOI: 10.1016/j.hjc.2021.03.008

No abstract available

Publication types

Letter

MeSH terms

Cardiomyopathy, Dilated* / complications
Cardiomyopathy, Dilated* / diagnosis
Cardiomyopathy, Dilated* / epidemiology
Death, Sudden, Cardiac
Defibrillators, Implantable*
Humans
Risk Assessment
Risk Factors